Critical values in the coagulation laboratory

American Journal of Clinical Pathology

Volumn 136, Issue 6, 2011, Pages 836-841

  Pai, Menaka ^a,b   Moffat, Karen A ^a,b   Plumhoff, Elizabeth ^c   Hayward, Catherine P M ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

^c MAYO CLINIC   (United States)

Author keywords

Coagulation; Critical values; Quality control; Standardization

Indexed keywords

FIBRINOGEN;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; CLINICAL PRACTICE; CRITICAL VALUE; DIAGNOSTIC VALUE; HOSPITAL PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; PERFORMANCE; PRIORITY JOURNAL; PROTHROMBIN TIME;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; CLINICAL LABORATORY INFORMATION SYSTEMS; FIBRINOGEN; HUMANS; INTERNATIONAL NORMALIZED RATIO; LABORATORIES; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; QUALITY CONTROL;

EID: 82655173727     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP8O8GIPPPNUSH     Document Type: Article

References (26)

1. Lundberg GD. Critical (panic) value notification: an established laboratory practice policy (parameter) [editorial]. JAMA. 1990;263:709. (Pubitemid 20042541)
2. The Joint Commission. National Patient Safety Goals. http://www. jointcommission.org/standards-information/npsgs.aspx. Accessed January 1, 2011.
3. Emancipator K. Critical values: ASCP practice parameter. American Society of Clinical Pathologists. Am J Clin Pathol. 1997;108:247-253.
4. Howanitz PJ, Steindel SJ, Heard NV. Laboratory critical values policies and procedures: a College of American Pathologists Q-Probes study in 623 institutions. Arch Pathol Lab Med. 2002;126:663-669. (Pubitemid 34602566)
5. Valenstein PN, Wagar EA, Stankovic AK, et al. Notification of critical results: a College of American Pathologists Q-Probes study of 121 institutions. Arch Pathol Lab Med. 2008;132:1862-1867.
6. Wagar EA, Stankovic AK, Wilkinson DS, et al. Assessment monitoring of laboratory critical values: a College of American Pathologists Q-Tracks study of 180 institutions. Arch Pathol Lab Med. 2007;131:44-49. (Pubitemid 46174134)
7. Wagar EA, Friedberg RC, Souers R, et al. Critical values comparison: a College of American Pathologists Q-Probes survey of 163 clinical laboratories. Arch Pathol Lab Med. 2007;131:1769-1775. (Pubitemid 350294575)
8. Don-Wauchope AC, Chetty VT. Laboratory defined critical value limits: how do hospital physicians perceive laboratory based critical values? Clin Biochem. 2009;42:766-770.
9. Hylek EM, Chang YC, Skates SJ, et al. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med. 2000;160:1612-1617. (Pubitemid 30367900)
10. Copland M, Walker ID, Tait RC. Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med. 2001;161:2125-2128.
11. Schulman S, Stigendal L, Jansson JH, et al. Haemorrhagic and thromboembolic complications versus intensity of treatment of venous thromboembolism with oral anticoagulants. Acta Med Scand. 1988;224:425-430. (Pubitemid 19052189)
12. The Stroke Prevention in Atrial Fibrillation Investigators. Bleeding during antithrombotic therapy in patients with atrial fibrillation. Arch Intern Med. 1996;156:409-416.
13. Fang MC, Chang Y, Hylek EM, et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med. 2004;141:745-752.
14. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 suppl):160S-198S. (Pubitemid 351892967)
15. Hirsh J, Bauer KA, Donati MB, et al. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 suppl):141S-159S. (Pubitemid 351892966)
16. Hochman JS, Wali AU, Gavrila D, et al. A new regimen for heparin use in acute coronary syndromes. Am Heart J. 1999;138:313-318. (Pubitemid 29379684)
17. Granger CB, Hirsch J, Califf RM, et al. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. Circulation. 1996;93:870-878.
18. Levi M, Toh CH, Thachil J, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009;145:24-33.
19. Ciavarella D, Reed RL, Counts RB, et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol. 1987;67:365-368. (Pubitemid 18022356)
20. Fairweather RB, Ansell J, van den Besselaar AM, et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy. Arch Pathol Lab Med. 1998;122:768-781.
21. Laposata M, Green D, Van Cott EM, et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. Arch Pathol Lab Med. 1998;122:799-807.
22. Bates SM, Weitz JI, Johnston M, et al. Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin. Arch Intern Med. 2001;161:385-391. (Pubitemid 32116554)
23. van den Besselaar AM, Sturk A, Reijnierse GL. Monitoring of unfractionated heparin with the activated partial thromboplastin time: determination of therapeutic ranges. Thromb Res. 2002;107:235-240. (Pubitemid 35435382)
24. Hayward CP, Moffat KA, Raby A, et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol. 2010;134:955-963.
25. Moffat KA, Ledford-Kraemer MR, Nichols WL, et al. Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association. Thromb Haemost. 2005;93:549-553. (Pubitemid 40392545)
26. Hayward CP, Moffat KA, Spitzer E, et al. Results of an external proficiency testing exercise on platelet dense-granule deficiency testing by whole mount electron microscopy. Am J Clin Pathol. 2009;131:671-675.